No-Test Telehealth Medication Abortion Services Provided by US-Based Clinicians in 21 States and the District of Columbia, 2020‒2022
- 1 February 2025
- journal article
- research article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 115 (2) , 221-231
Abstract
Objectives. To evaluate the association between distance from closest abortion facility and number of fulfilled requests through no-test telehealth medication abortion (NTMA) asynchronous service. Methods. Using deidentified 2020–2022 electronic medical record data from Aid Access users in US states where NTMA is prescribed by US-based clinicians, we describe individual user demographics and their resident county characteristics. We conducted a county-level geospatial analysis of distance to abortion facility (Myers Abortion Facility Database) on fulfilled requests using Poisson regression. Results. US-based clinicians fulfilled NTMA requests to 8411 individuals in 21 states and the District of Columbia. Each 100-mile increase in distance to an abortion facility increased per-capita NTMA by 61% (95% confidence interval [CI] = 26%, 86%). Most individuals were aged 20 to 29 years (54%), had no living children (57%), were less than 6 weeks’ gestation (62%), and lived in urban areas (65%). Almost half (49%) lived in higher socially vulnerable counties compared with 17% in less socially vulnerable counties. Conclusions. In the United States, telehealth medication abortion is a critically important service for individuals who are young, socially vulnerable, and living in counties far from abortion care facilities. Public Health Implications. With abortion now banned or highly restricted in 22 US states, telehealth abortion services are necessary to maintain essential reproductive health services. ( Am J Public Health. 2025;115(2):221–231. https://doi.org/10.2105/AJPH.2024.307892 )Keywords
This publication has 23 references indexed in Scilit:
- Comparison of No-Test Telehealth and In-Person Medication AbortionJAMA, 2024
- Forecasts for a post‐Roe America: The effects of increased travel distance on abortions and birthsJournal of Policy Analysis and Management, 2023
- Characteristics of people obtaining medication vs procedural abortions in clinical settings in the United States: Findings from the 2021–2022 Abortion Patient SurveyContraception, 2023
- The social vulnerability index as a risk stratification tool for health disparity research in cancer patients: a scoping reviewCancer Causes & Control, 2023
- Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰Contraception, 2022
- Family medicine provision of online medication abortion in three US states during COVID-19Contraception, 2021
- Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the USJAMA Network Open, 2021
- Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyondContraception, 2020
- TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United StatesContraception, 2019
- Contraception Is a Fundamental Primary Care Service2013